Cargando…
Clinical review: Use of vancomycin in haemodialysis patients
Following intravenous administration, vancomycin is poorly metabolized and is mainly excreted unchanged in urine. Total body clearance is thus dependent on the kidney, and is correlated with glomerular filtration rate and creatinine clearance. Accumulation of vancomycin in patients with renal insuff...
Autores principales: | Launay-Vacher, Vincent, Izzedine, Hassane, Mercadal, Lucile, Deray, Gilbert |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137311/ https://www.ncbi.nlm.nih.gov/pubmed/12225605 |
Ejemplares similares
-
How to define a cut-off value of tumour markers in haemodialysis patients?
por: Mercadal, Lucile, et al.
Publicado: (2009) -
Renal insufficiency and cancer treatments
por: Launay-Vacher, Vincent, et al.
Publicado: (2016) -
Renal effects of BRAF inhibitors: a systematic review by the Cancer and the Kidney International Network
por: Wanchoo, Rimda, et al.
Publicado: (2016) -
ANCA-positive pauci-immune glomerulonephritis and febuxostat treatment
por: Izzedine, Hassane, et al.
Publicado: (2012) -
Acute Tubular Necrosis and Interstitial Nephritis during Pemetrexed Therapy
por: Michels, Judith, et al.
Publicado: (2009)